ALEMG Stock Overview
Euromedis Groupe designs, manufactures, and distributes medical equipment under the Euromedis brand for healthcare professionals, local communities, and individuals in France.
+ 1 more risk
Euromedis Groupe Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€6.11|
|52 Week High||€17.76|
|52 Week Low||€4.85|
|1 Month Change||-27.95%|
|3 Month Change||-23.34%|
|1 Year Change||-64.89%|
|3 Year Change||-8.12%|
|5 Year Change||-22.36%|
|Change since IPO||19.80%|
Recent News & Updates
Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality
Euromedis Groupe ( EPA:ALEMG ) just reported some strong earnings, and the market rewarded them with a positive share...
|ALEMG||FR Medical Equipment||FR Market|
Return vs Industry: ALEMG underperformed the French Medical Equipment industry which returned -5.9% over the past year.
Return vs Market: ALEMG underperformed the French Market which returned -5.4% over the past year.
|ALEMG Average Weekly Movement||12.0%|
|Medical Equipment Industry Average Movement||7.0%|
|Market Average Movement||6.1%|
|10% most volatile stocks in FR Market||10.4%|
|10% least volatile stocks in FR Market||3.6%|
Stable Share Price: ALEMG is more volatile than 90% of French stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: ALEMG's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
Euromedis Groupe designs, manufactures, and distributes medical equipment under the Euromedis brand for healthcare professionals, local communities, and individuals in France. It offers sterile or non-sterile medical gloves, dressings and compresses, medical sets, parenteral approach, needles, syringes, infusers, catheters, etc.; and the surgical range with wound drainage products, probes, and a draping range for operating theaters, as well as surgical gloves and protective covers. The company also provides oxygen therapy; incontinence and various hygiene-related products; a range of diagnostics; and a range of home care products.
Euromedis Groupe Fundamentals Summary
|ALEMG fundamental statistics|
Is ALEMG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ALEMG income statement (TTM)|
|Cost of Revenue||€78.41m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.75|
|Net Profit Margin||2.02%|
How did ALEMG perform over the long term?See historical performance and comparison
Is Euromedis Groupe undervalued compared to its fair value and its price relative to the market?
Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ALEMG (€6.11) is trading below our estimate of fair value (€228.79)
Significantly Below Fair Value: ALEMG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ALEMG is good value based on its PE Ratio (8.1x) compared to the French Medical Equipment industry average (13.6x).
PE vs Market: ALEMG is good value based on its PE Ratio (8.1x) compared to the French market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: ALEMG is good value based on its PEG Ratio (0.5x)
Price to Book Ratio
PB vs Industry: ALEMG is good value based on its PB Ratio (0.4x) compared to the FR Medical Equipment industry average (2.2x).
How is Euromedis Groupe forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALEMG's forecast earnings growth (17.6% per year) is above the savings rate (0.3%).
Earnings vs Market: ALEMG's earnings (17.6% per year) are forecast to grow faster than the French market (12% per year).
High Growth Earnings: ALEMG's earnings are forecast to grow, but not significantly.
Revenue vs Market: ALEMG's revenue is expected to decline over the next 3 years (-15.1% per year).
High Growth Revenue: ALEMG's revenue is forecast to decline over the next 3 years (-15.1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALEMG's Return on Equity is forecast to be low in 3 years time (6.1%).
How has Euromedis Groupe performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ALEMG has a large one-off loss of €1.4M impacting its December 31 2021 financial results.
Growing Profit Margin: ALEMG's current net profit margins (2%) are lower than last year (11.7%).
Past Earnings Growth Analysis
Earnings Trend: ALEMG's earnings have grown significantly by 47.9% per year over the past 5 years.
Accelerating Growth: ALEMG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ALEMG had negative earnings growth (-90%) over the past year, making it difficult to compare to the Medical Equipment industry average (22.5%).
Return on Equity
High ROE: ALEMG's Return on Equity (5.6%) is considered low.
How is Euromedis Groupe's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ALEMG's short term assets (€64.4M) exceed its short term liabilities (€13.2M).
Long Term Liabilities: ALEMG's short term assets (€64.4M) exceed its long term liabilities (€18.3M).
Debt to Equity History and Analysis
Debt Level: ALEMG has more cash than its total debt.
Reducing Debt: ALEMG's debt to equity ratio has increased from 27.3% to 37% over the past 5 years.
Debt Coverage: ALEMG's debt is well covered by operating cash flow (126.1%).
Interest Coverage: ALEMG's interest payments on its debt are well covered by EBIT (12.6x coverage).
What is Euromedis Groupe current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ALEMG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ALEMG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ALEMG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALEMG's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: ALEMG is not paying a notable dividend for the French market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ALEMG has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Mr. Mathieu Roturier serves as the Chief Executive Officer at Sa Laboratoires Euromedis. Mr. Roturier serves as a Manager at Sarl Laboratoires Euromedis Italie. He serves as the Chairman of the Board of Di...
CEO Compensation Analysis
Compensation vs Market: Mathieu's total compensation ($USD305.43K) is about average for companies of similar size in the French market ($USD284.13K).
Compensation vs Earnings: Mathieu's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.8%.
Euromedis Groupe's employee growth, exchange listings and data sources
- Name: Euromedis Groupe
- Ticker: ALEMG
- Exchange: ENXTPA
- Founded: 1985
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: €18.269m
- Shares outstanding: 2.99m
- Website: https://www.euromedis.fr
Number of Employees
- Euromedis Groupe
- Zi De La Tuilerie
- Neuilly Sous Clermont
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/21 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.